HK1149907A1 - Pharmaceutical formulation for treating the upper digestive tract - Google Patents

Pharmaceutical formulation for treating the upper digestive tract

Info

Publication number
HK1149907A1
HK1149907A1 HK11104202.3A HK11104202A HK1149907A1 HK 1149907 A1 HK1149907 A1 HK 1149907A1 HK 11104202 A HK11104202 A HK 11104202A HK 1149907 A1 HK1149907 A1 HK 1149907A1
Authority
HK
Hong Kong
Prior art keywords
treating
pharmaceutical formulation
digestive tract
upper digestive
antiinflammatory
Prior art date
Application number
HK11104202.3A
Other languages
English (en)
Inventor
Rudolf Wilhelm
Markus Proels
Original Assignee
Falk Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39951664&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1149907(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Falk Pharma Gmbh filed Critical Falk Pharma Gmbh
Publication of HK1149907A1 publication Critical patent/HK1149907A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
HK11104202.3A 2008-07-21 2011-04-27 Pharmaceutical formulation for treating the upper digestive tract HK1149907A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08013091A EP2151235B1 (de) 2008-07-21 2008-07-21 Pharmazeutische Formulierung zur Behandlung des oberen Verdauungstraktes
PCT/EP2009/058320 WO2010009961A1 (de) 2008-07-21 2009-07-02 Pharmazeutische formulierung zur behandlung des oberen verdauungstraktes

Publications (1)

Publication Number Publication Date
HK1149907A1 true HK1149907A1 (en) 2011-10-21

Family

ID=39951664

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11104202.3A HK1149907A1 (en) 2008-07-21 2011-04-27 Pharmaceutical formulation for treating the upper digestive tract

Country Status (24)

Country Link
US (2) US8580300B2 (es)
EP (2) EP2151235B1 (es)
JP (2) JP5616889B2 (es)
CN (1) CN102159196B (es)
AT (1) ATE498396T1 (es)
AU (1) AU2009273361B2 (es)
CA (1) CA2731312C (es)
CY (2) CY1111878T1 (es)
DE (1) DE502008002621D1 (es)
DK (2) DK2151235T3 (es)
EA (1) EA018465B1 (es)
ES (2) ES2358158T3 (es)
HK (1) HK1149907A1 (es)
HR (2) HRP20110208T1 (es)
IL (1) IL210779A (es)
ME (2) ME01256B (es)
NZ (1) NZ590593A (es)
PL (2) PL2151235T3 (es)
PT (2) PT2151235E (es)
RS (2) RS51649B (es)
SI (2) SI2151235T1 (es)
UA (1) UA100759C2 (es)
WO (1) WO2010009961A1 (es)
ZA (1) ZA201100283B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8895064B2 (en) * 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
PT1183014E (pt) 1999-06-14 2003-12-31 Cosmo Spa Composicoes farmaceuticas orais de libertacao controlada e de dissimulacao de sabor
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
DE502008002621D1 (de) * 2008-07-21 2011-03-31 Falk Pharma Gmbh Pharmazeutische Formulierung zur Behandlung des oberen Verdauungstraktes
EP2440210A4 (en) 2009-06-12 2014-01-29 Meritage Pharma Inc METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
CA3037273C (en) 2009-10-01 2022-05-03 Fredric Jay Cohen Orally administered corticosteroid compositions
US10154964B2 (en) 2011-09-07 2018-12-18 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
PL2886108T5 (pl) * 2013-12-23 2023-02-27 Dr. Falk Pharma Gmbh Zoptymalizowana formulacja farmaceutyczna do leczenia zmian zapalnych przełyku
TWI728172B (zh) 2016-08-18 2021-05-21 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4332394A1 (de) 1993-09-23 1995-03-30 Falk Pharma Gmbh Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung
US5639475A (en) * 1995-02-03 1997-06-17 Eurand America, Incorporated Effervescent microcapsules
US5607697A (en) * 1995-06-07 1997-03-04 Cima Labs, Incorporated Taste masking microparticles for oral dosage forms
US5807577A (en) * 1995-11-22 1998-09-15 Lab Pharmaceutical Research International Inc. Fast-melt tablet and method of making same
US5807578A (en) * 1995-11-22 1998-09-15 Lab Pharmaceutical Research International Inc. Fast-melt tablet and method of making same
GB9611364D0 (en) * 1996-05-31 1996-08-07 Smithkline Beecham Plc Composition
US6350470B1 (en) * 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
JP3818789B2 (ja) * 1999-02-18 2006-09-06 三菱化学フーズ株式会社 易崩壊性錠剤
JP4038772B2 (ja) 2001-07-11 2008-01-30 敏朗 関根 光合成微生物の培養方法と装置
BR0212807A (pt) * 2001-09-25 2004-10-05 Ranbaxy Lab Ltd Processo para a preparação de formas de dosagem de dissolução rápida
CA2467747A1 (en) * 2001-11-20 2003-05-30 Dmi Biosciences, Inc. Methods and products for oral care
WO2003080023A2 (en) * 2002-03-20 2003-10-02 Elan Pharma International Limited Fast dissolving dosage forms having reduced friability
SE0401031D0 (sv) * 2004-04-22 2004-04-22 Duocort Ab A new glucocorticoid replacement therapy
US20060013873A1 (en) * 2004-07-16 2006-01-19 Chih-Chiang Yang Bioadhesive dosage form of steroids
US20070071817A1 (en) * 2005-09-26 2007-03-29 Phyzz, Inc. Effervescent oral care compositions and method of use
EP1993598A2 (en) * 2006-02-15 2008-11-26 Tika Läkemedel AB Methods of manufacturing corticosteroid solutions
LT2170348T (lt) * 2007-06-22 2016-11-25 DompĆ© farmaceutici s.p.a. Putojančios tabletės skirtos inhaliaciniam vartojimui
PL2572705T3 (pl) * 2007-10-01 2018-01-31 Lesvi Laboratorios Sl Tabletki ulegające rozpadowi w jamie ustnej
DE502008002621D1 (de) * 2008-07-21 2011-03-31 Falk Pharma Gmbh Pharmazeutische Formulierung zur Behandlung des oberen Verdauungstraktes
EP2440210A4 (en) * 2009-06-12 2014-01-29 Meritage Pharma Inc METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES

Also Published As

Publication number Publication date
HRP20130171T1 (hr) 2013-03-31
JP2014221827A (ja) 2014-11-27
IL210779A0 (en) 2011-03-31
EP2306988B1 (de) 2013-01-09
ZA201100283B (en) 2011-10-26
ES2399321T3 (es) 2013-03-27
PL2306988T3 (pl) 2013-04-30
AU2009273361B2 (en) 2014-03-20
SI2151235T1 (sl) 2011-04-29
CY1113719T1 (el) 2016-06-22
ATE498396T1 (de) 2011-03-15
EP2151235B1 (de) 2011-02-16
EA018465B1 (ru) 2013-08-30
NZ590593A (en) 2012-07-27
DE502008002621D1 (de) 2011-03-31
CA2731312A1 (en) 2010-01-28
CN102159196A (zh) 2011-08-17
WO2010009961A1 (de) 2010-01-28
EP2306988A1 (de) 2011-04-13
US20110123460A1 (en) 2011-05-26
AU2009273361A1 (en) 2010-01-28
EA201100229A1 (ru) 2011-08-30
RS51649B (en) 2011-10-31
CY1111878T1 (el) 2015-11-04
US20140079646A1 (en) 2014-03-20
HRP20110208T1 (hr) 2011-04-30
JP5616889B2 (ja) 2014-10-29
PL2151235T3 (pl) 2011-05-31
US8580300B2 (en) 2013-11-12
CA2731312C (en) 2016-05-10
JP6209495B2 (ja) 2017-10-04
DK2151235T3 (da) 2011-04-11
EP2151235A1 (de) 2010-02-10
JP2011528679A (ja) 2011-11-24
ES2358158T3 (es) 2011-05-06
ME01256B (me) 2013-06-20
DK2306988T3 (da) 2013-03-18
PT2306988E (pt) 2013-02-15
SI2306988T1 (sl) 2013-03-29
IL210779A (en) 2015-07-30
RS52662B (en) 2013-06-28
CN102159196B (zh) 2013-05-08
ME01494B (me) 2014-04-20
UA100759C2 (uk) 2013-01-25
PT2151235E (pt) 2011-03-21

Similar Documents

Publication Publication Date Title
HK1149907A1 (en) Pharmaceutical formulation for treating the upper digestive tract
AR114143A2 (es) Formulaciones de comprimidos revestidos
WO2009064460A3 (en) Gastrointestinal delivery systems
EP2440210A4 (en) METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
WO2010127099A3 (en) Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
WO2009014650A3 (en) Recombinant vibrio cholerae exotoxins
WO2011112229A3 (en) Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
WO2008028193A3 (en) Colon-targeted oral formulations of cytidine analogs
HK1148202A1 (en) Pharmaceutical solutions, process of preparation and therapeutic uses
WO2009111611A3 (en) Compounds, compositions and methods for the treatment of islet amyloid polypeptide (iapp) accumulation in diabetes
FR2953142B1 (fr) Appareil de delivrance regulee d'un gaz,notamment appareil d'assistance respiratoire
WO2009031606A1 (ja) 関節炎治療及び予防剤
TN2012000279A1 (en) Processes for the manufacture of a pharmaceutically active agent
WO2011072069A3 (en) Gastric retentive pharmaceutical compositions for extended release of polypeptides
EP2258374A4 (en) USE OF MASLINIC ACID FOR THE TREATMENT OF DISEASES AND THEIR SYMPTOMS THROUGH COX-2 INHIBITION
WO2010148314A3 (en) Preparation of esomeprazole and its pharmaceutically acceptable salts
WO2011113000A8 (en) Novel ester containing compositions and methods
EP2023894A4 (en) FIXED COMBINATION DOSAGE FOR TREATING MIGRAINE
WO2012064130A3 (ko) 대장 선택성 셀레콕시브 전구체 화합물 및 이를 유효성분으로 함유하는 대장성 질환 치료 또는 예방용 약학조성물
IL207977A0 (en) Therapy for disorders of the proximal digestive tract
WO2007138577A3 (en) Methods of generating a neural tissue using muscle-derived cells
UA96289C2 (ru) Способ получения лекарственного средства на основе ингибитора протеаз распылительной сушкой (варианты) и препарат (варианты)
UA38368U (ru) Лечебно-профилактический фитосироп "иммуностимулин"
WO2010124873A8 (en) 3- (2, 2, 2, trimethylhydrazinium) propionate dihydrate (meldonium) for treating parkinson' s disease
WO2007100623A3 (en) Hydroxylamines and derivatives for the inhibition of complement activation

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190628